The sobering fact about drug development is that it takes too long and costs too much money. 23andMe wants to change all that. At the annual meeting of the American Society of Human Genetics this month, 23andMe computational biologist Fah Sathirapongsasuti offered some insight into how this is being done. “It’s a well-appreciated fact among […]
